-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$7.33560.36% Upside
Ovid Therapeutics Inc. Frequently Asked Questions
-
What analysts cover Ovid Therapeutics Inc.?
Ovid Therapeutics Inc. has been rated by research analysts at H.C. Wainwright, BTIG, Oppenheimer in the past 90 days.